Rheumatoid arthritis
2018 · Nature Reviews Disease Primers · 2,374 citations
https://doi.org/10.1038/nrdp.2018.1
V
Vibeke Strand
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
763
Papers
35.3K
Citations
93
h-index
363
i10-index
Vibeke Strand is an academic researcher from Stanford University. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Autoimmune and Inflammatory Disorders Research & Systemic Lupus Erythematosus Research. The author has an h-index of 93, co-authored 649 publications.
ORCID: 0000-0003-4978-4072Papers by this author
worksOMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
2004 · Osteoarthritis and Cartilage · 839 citations
https://doi.org/10.1016/j.joca.2004.02.001
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
2008 · Annals of the Rheumatic Diseases · 489 citations
https://doi.org/10.1136/ard.2008.101659
Mechanism of Action for Leflunomide in Rheumatoid Arthritis
1999 · Clinical Immunology · 404 citations
https://doi.org/10.1006/clim.1999.4777
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
2013 · Annals of the Rheumatic Diseases · 323 citations
https://doi.org/10.1136/annrheumdis-2012-202760
Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
2015 · Arthritis Research & Therapy · 216 citations
https://doi.org/10.1186/s13075-015-0880-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat